Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Anika Therapeutics Inc. (ANIK) had Weighted-Average Shares Outstanding (Diluted) of 14.34M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$112.82M |
|
$-10.88M |
|
$49.01M |
|
$63.81M |
|
$123.87M |
|
$-11.05M |
|
$1.74M |
|
$-9.31M |
|
$-9.31M |
|
$-9.98M |
|
$-9.98M |
|
$-10.88M |
|
$-9.98M |
|
$-11.05M |
|
$-5.32M |
|
14.34M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
14.34M |
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$103.36M |
|
$40.32M |
|
$86.91M |
|
$190.27M |
|
$21.91M |
|
-- |
|
$24.90M |
|
$46.80M |
|
$143.47M |
|
$133.76M |
|
$143.47M |
|
13.89M |
|
| Cash Flow Statement Financials | |
$11.19M |
|
$-0.40M |
|
$-10.55M |
|
$57.16M |
|
$57.48M |
|
$0.32M |
|
$10.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
56.56% |
|
-9.80% |
|
-9.80% |
|
-4.72% |
|
-8.25% |
|
-9.64% |
|
$4.96M |
|
-- |
|
-- |
|
-- |
|
0.59 |
|
2.61 |
|
4.76 |
|
76.64 |
|
-6.96% |
|
-7.46% |
|
-5.24% |
|
-6.96% |
|
$10.33 |
|
$0.35 |
|
$0.78 |
|